R

Rakesh Kumar

Karolinska Institutet

ORCID: 0000-0003-2029-8687

Publishes on Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Catalytic Processes in Materials Science. 117 papers and 3.1k citations.

117Publications
3.1kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Plant-Mediated Green Synthesis of Iron Nanoparticles
Mihir Herlekar, Siddhivinayak Barve, Rakesh Kumar|Journal of Nanoparticles|2014
Cited by 351Open Access

In the recent years, nanotechnology has emerged as a state-of-the-art and cutting edge technology with multifarious applications in a wide array of fields. It is a very broad area comprising of nanomaterials, nanotools, and nanodevices. Amongst nanomaterials, majority of the research has mainly focused on nanoparticles as they can be easily prepared and manipulated. Physical and chemical methods are conventionally used for the synthesis of nanoparticles; however, due to several limitations of these methods, research focus has recently shifted towards the development of clean and eco-friendly synthesis protocols. Magnetic nanoparticles constitute an important class of inorganic nanoparticles, which find applications in different areas by virtue of their several unique properties. Nevertheless, in comparison with biological synthesis protocols for noble metal nanoparticles, limited study has been carried out with respect to biological synthesis of magnetic nanoparticles. This review focuses on various studies outlining the novel routes for biosynthesis of these nanoparticles by plant resources along with outlining the future scope of work in this area.

Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function
Dipita Bhattacharyya, Ganesh M. Mohite, Janarthanan Krishnamoorthy et al.|ACS Chemical Neuroscience|2019
Cited by 104

Altered intestinal permeability has been correlated with Parkinson's pathophysiology in the enteric nervous system, before manifestations in the central nervous system (CNS). The inflammatory endotoxin or lipopolysaccharide (LPS) released by gut bacteria is known to modulate α-synuclein amyloidogenesis through the formation of intermediate nucleating species. Here, biophysical techniques in conjunction with microscopic images revealed the molecular interaction between lipopolysaccharide and α-synuclein that induce rapid nucleation events. This heteromolecular interaction stabilizes the α-helical intermediates in the α-synuclein aggregation pathway. Multitude NMR studies probed the residues involved in the LPS-binding structural motif that modulates the nucleating forms, affecting the cellular internalization and associated cytotoxicity. Collectively, our data characterizes this heteromolecular interaction associated with an alternative pathway in Parkinson's disease progression.